Cardiometabolic Protection
Cardiology · Endocrinology · Lipidology
Atherosclerosis and insulin resistance develop across decades. This programme characterises plaque burden, lipoprotein biology, blood-pressure phenotype and glucose dynamics, then targets the modifiable drivers with graded, monitored intervention.
- Coronary calcium and cardiac MRI
- Lipoprotein subfraction and Lp(a) profiling
- Ambulatory blood-pressure phenotyping
- Continuous glucose and insulin-sensitivity assessment

